Clincosm LogoSign in Get a demo

metastatic breast cancer

Showing 51 - 75 of 726
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Germline and Somatic Pathogenic Variants in de Novo Metastatic

Active, not recruiting
  • Metastatic Breast Cancer
  • NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
  • Athens, Greece
    Evangelia Moirogiorgou
Mar 7, 2023

PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

Not yet recruiting
  • PIK3CA Mutation
  • +7 more
  • (no location specified)
Mar 7, 2023

Discovering Factors in Metastatic Breast Cancer Patients'

Not yet recruiting
  • Metastatic Breast Cancer
    • (no location specified)
    Feb 25, 2023

    Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Haifa, Israel
      Rambam Health Care Campus
    Feb 22, 2023

    Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Spain (Trastuzumab deruxtecan)

    Not yet recruiting
    • Locally Advanced Breast Cancer
    • Metastatic Breast Cancer
    • Trastuzumab deruxtecan
    • Cádiz, Andalucía, Spain
    • +18 more
    Feb 24, 2023

    Metastatic Breast Cancer Trial in Italy (Both blood and tissues collection for patients with metastatic breast cancer HER2+

    Completed
    • Metastatic Breast Cancer
    • Both blood and tissues collection for patients with metastatic breast cancer HER2+ pretreated with no more than one line of anti-HER2 therapy for advanced breast cancer.
    • Bergamo, Italy
    • +8 more
    Feb 9, 2023

    Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction Trial in Lørenskog (Nicotinamide Riboside,

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • Nicotinamide Riboside
    • Placebo
    • Lørenskog, Akershus, Norway
      Akershus University Hospital
    Feb 14, 2023

    Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Boston (Cessation of anti-HER2 treatment)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • Cessation of anti-HER2 treatment
    • Boston, Massachusetts
    • +1 more
    Feb 9, 2023

    Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

    Recruiting
    • Premenopausal Breast Cancer
    • +2 more
    • Taipei City, Taiwan
      Department of Oncology, National Taiwan University Hospital
    Feb 7, 2023

    Metastatic Breast Cancer Trial (Estradiol)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Feb 6, 2023

    Metastatic Breast Cancer Trial in Herlev, Vejle (PARP inhibitor 2X-121)

    Active, not recruiting
    • Metastatic Breast Cancer
    • PARP inhibitor 2X-121
    • Herlev, Denmark
    • +1 more
    Feb 1, 2023

    Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane

    Recruiting
    • Metastatic Breast Cancer
    • Enobosarm & Abemaciclib Combo
    • non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
    • Chandler, Arizona
    • +29 more
    Feb 1, 2023

    Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • Washington, District of Columbia
    • +4 more
    Jan 31, 2023

    Assessing the Time Demands of Cancer

    Not yet recruiting
    • Metastatic Breast Cancer
    • Ovarian Cancer
      • Birmingham, Alabama
      • +1 more
      Jan 31, 2023

      Metastatic Breast Cancer, FGFR 1 High Amplification, FGFR2 Amplification Trial in Worldwide (Futibatinib, Futibatinib plus

      Recruiting
      • Metastatic Breast Cancer
      • +2 more
      • Phoenix, Arizona
      • +36 more
      Jan 27, 2023

      Metastatic Breast Cancer, Metastatic Prostate Cancer, Bone Metastases Trial in Austria, Germany, Switzerland (Denosumab (reduced

      Recruiting
      • Metastatic Breast Cancer
      • +2 more
      • Denosumab (reduced dosing)
      • Denosumab (standard dosing)
      • Feldkirch, Austria
      • +49 more
      Jan 30, 2023

      Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

      Not yet recruiting
      • Metastatic Lung Cancer
      • +2 more
      • Tusamitamab ravtansine
      • Rotterdam, Netherlands
        Erasmus MC
      Jan 26, 2023

      Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (LY3484356, Abemaciclib, Everolimus)

      Recruiting
      • Breast Cancer
      • +3 more
      • Gilbert, Arizona
      • +76 more
      Jan 27, 2023

      Metastatic Breast Cancer Trial (Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib)

      Not yet recruiting
      • Metastatic Breast Cancer
      • Lasofoxifene in combination with abemaciclib
      • Fulvestrant in combination with abemaciclib
      • (no location specified)
      Jan 25, 2023

      Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Metastatic Breast Cancer
      • Sacituzumab govitecan
      • (no location specified)
      Jan 23, 2023

      Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Hospitalet de Llobregat, Barcelona, Spain
      • +6 more
      Jan 23, 2023

      Invasive Mammary Carcinoma, Metastatic Breast Cancer Trial in Nashville (Capecitabine, Endocrine-therapy, MammoPrint ® and

      Not yet recruiting
      • Invasive Mammary Carcinoma
      • Metastatic Breast Cancer
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Jan 11, 2023

      FES F18 PET/CT in Metastatic Breast Cancer Patients

      Recruiting
      • Metastatic Breast Cancer
      • 18F Fluoroestradiol Radiopharmaceutical with PET/CT
      • Long Beach, California
      • +5 more
      Jan 19, 2023

      Metastatic Breast Cancer Trial in Charlottesville (HER2 BATs with Pembrolizumab)

      Recruiting
      • Metastatic Breast Cancer
      • HER2 BATs with Pembrolizumab
      • Charlottesville, Virginia
        Ashley Donihee
      Jan 18, 2023

      Real-World Data of Clinicopathological Characteristics and

      Recruiting
      • Early Breast Cancer
      • +2 more
        • Barcelona, Spain
        • +9 more
        Jan 18, 2023